Navigation Links
Vaccine for Alzheimer’s diseas

Researchers developing a vaccine against Alzheimer’s disease have shown that it seems to stop mice with the condition losing their memory. The results boost hopes that such vaccines could delay or prevent similar symptoms in people.

The vaccines reduces the build-up of protein deposits in mouse brains -the other major indicator of Alzheimer’s diseases. The pharmaceutical company Elan, based in Dublin, Ireland, is poised to begin human clinical trails of a potential treatment based on the vaccine.

Nearly one in ten people over the age of 65 suffers the dementia by Alzheimer’s disease, and the risk rises fourfold for those over 80. Several genes have been linked to the condition – particularly one that codes for a protein known as beta-amyloid peptide.

Mutations to this gene cause the protein to be over produced, forming the fibrous plagues in the brains of Alzheimer’s patients and killing the nerve cells.

When Alzheimer’s mice are vaccinated with beta-amyloid peptide they develop antibodies against the protein, which sweep the brain clean of the plagues.

Mice given the test vaccine developed fewer protein deposits in their brains compared with unvaccinated animals. These results are reported in Nature.

Whether the protein deposits actually cause dementia in people is something of an open question among Alzheimer’s researchers. However, the mouse models don’t seem to show the same neural destruction suffered by human patients. But it is certainly encouraging and one can hope that some kind of human application willfollow.
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Health Officials Recommend Flu Vaccine
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Panacea Biotech To Market Anthrax Vaccine
6. New Prostate Cancer Vaccine Shows Promise
7. Drug Firm Offers to Donate Smallpox Vaccine
8. Vaccine guards against shingles
9. Vaccine for septic conditions
10. A new Vaccine for Pneumonia
11. Vaccine Reduces antibiotic-resistant infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX ... media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes ... use drop zones. Editors can select from a variety of flip book animations. In ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare ... enhances the WellnessPro platform by expanding the treatment modalities available in a ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
(Date:12/6/2016)... With opioids commonly used for pain management for workplace ... that has led to nationwide fatalities. The synthetic opioid ... than heroin or morphine, resulting in likelihood of addiction, abuse or ... , , ... operations, Behavioral Health for HMC HealthWorks, explained the opioid drug is ...
(Date:12/6/2016)... , Dec. 6, 2016  Blueprint Medicines Corporation ... and developing targeted kinase medicines for patients with genomically ... underwritten public offering of $125,000,000 million in shares of ... grant the underwriters a 30-day option to purchase up ... its common stock in connection with the public offering. ...
Breaking Medicine Technology: